Nasdaq

Bio-Rad (BIO) Banks on Blood Typing Market Amid Margin Woes

On Aug 13, we issued an updated research report on Bio-Rad Laboratories, Inc.BIO. We are upbeat about the company gaining from solid prospects in the blood typing market, while declining gross margin ...
Nasdaq

Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510 ...